| Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook JA Greene, NK Choudhry, E Kilabuk, WH Shrank Journal of general internal medicine 26, 287-292, 2011 | 1047 | 2011 |
| The economic impact of Staphylococcus aureus infection in New York City hospitals. RJ Rubin, CA Harrington, A Poon, K Dietrich, JA Greene, A Moiduddin Emerging infectious diseases 5 (1), 9, 1999 | 691 | 1999 |
| Prescribing by numbers: drugs and the definition of disease JA Greene JHU Press, 2007 | 662 | 2007 |
| Assessing the gold standard—lessons from the history of RCTs LE Bothwell, JA Greene, SH Podolsky, DS Jones N engl j med 374 (22), 2175-2181, 2016 | 631 | 2016 |
| The burden of disease and the changing task of medicine DS Jones, SH Podolsky, JA Greene New England Journal of Medicine 366 (25), 2333-2338, 2012 | 453 | 2012 |
| Putting the patient back together—social medicine, network medicine, and the limits of reductionism JA Greene, J Loscalzo New England Journal of Medicine 377 (25), 2493-2499, 2017 | 181 | 2017 |
| Reform, regulation, and pharmaceuticals—the Kefauver–Harris Amendments at 50 JA Greene, SH Podolsky New England Journal of Medicine 367 (16), 1481-1483, 2012 | 172 | 2012 |
| Variations in pill appearance of antiepileptic drugs and the risk of nonadherence AS Kesselheim, AS Misono, WH Shrank, JA Greene, M Doherty, J Avorn, ... JAMA internal medicine 173 (3), 202-208, 2013 | 148 | 2013 |
| Generic: The unbranding of modern medicine JA Greene Johns Hopkins University Press, 2016 | 141 | 2016 |
| Pharmaceutical marketing and the new social media JA Greene, AS Kesselheim New England Journal of Medicine 363 (22), 2087-2089, 2010 | 138 | 2010 |
| Colonial medicine and its legacies J Greene, MT Basilico, H Kim, P Farmer Reimagining global health: an introduction 1, 33-73, 2013 | 121 | 2013 |
| An ethnography of nonadherence: culture, poverty, and tuberculosis in urban Bolivia JA Greene Culture, Medicine and Psychiatry 28, 401-425, 2004 | 120 | 2004 |
| Why is there no generic insulin? Historical origins of a modern problem JA Greene, KR Riggs New England Journal of Medicine 372 (12), 1171-1175, 2015 | 115 | 2015 |
| Making the case for history in medical education DS Jones, JA Greene, J Duffin, J Harley Warner Journal of the history of medicine and allied sciences 70 (4), 623-652, 2015 | 108 | 2015 |
| Why do the same drugs look different? Pills, trade dress, and public health JA Greene, AS Kesselheim New England Journal of Medicine 365 (1), 83-89, 2011 | 108 | 2011 |
| Hidden in plain sight marketing prescription drugs to consumers in the twentieth century JA Greene, D Herzberg American Journal of Public Health 100 (5), 793-803, 2010 | 105 | 2010 |
| Attention to ‘details’: etiquette and the pharmaceutical salesman in postwar American JA Greene Social Studies of Science 34 (2), 271-292, 2004 | 104 | 2004 |
| Attacks on public health officials during COVID-19 MM Mello, JA Greene, JM Sharfstein Jama 324 (8), 741-742, 2020 | 98 | 2020 |
| Making medicines essential: The emergent centrality of pharmaceuticals in global health JA Greene BioSocieties 6, 10-33, 2011 | 92 | 2011 |
| Case studies in social medicine—attending to structural forces in clinical practice SD Stonington, SM Holmes, H Hansen, JA Greene, KA Wailoo, D Malina, ... New England Journal of Medicine 379 (20), 1958-1961, 2018 | 89 | 2018 |
